Dental Tribune International
Edition International
International
Americas
Europe
Asia Pacific
Middle East & Africa

CORONAVIRUS
LIVE UPDATES

Leading dental schools uniteWhat we know about a SARS-CoV-2 vaccine so farStudy indicates 16% of UK dental professionals may have had COVID-19Less than 1% of dentists in the U.S. affected by COVID-19, study findsSunshine vitamin D and COVID-19: Is there a correlation?Fallow time calculator launched after AGP reviewOrganisers of IDS determine new guidelines for 2021 eventPeriodontal status may play role in COVID-19 severityThe dental hygienist in times of COVID-19Survey shows UK periodontists feel let down by government and regulators during pandemic
Visit microsite
home / who’s who

Dr. Nazariy Mykhaylyuk

Address: 25A, Franka Str., Ivano-Frankivsk, Ukraine
Phone:
Fax:
Website: https://mvision.pro/
Email:

Short CV

Dr. Mykhaylyuk graduated from Ivano-Frankivsk Dental Academy (Ukraine) in 2008.

He specializes in micro-dentistry, focusing on indirect restorations, and practices at his family owned practice, Dental Clinic of Mykhaylyuk – Oral Design Center,  in Ivano-Frankivsk Ukraine.

Dr. Mykhayluk is an official trainer of the Carl Zeiss Dental Academy, DSD lecturer and co-founder of MicroVision Group.

advertisement
Content you may be interested in:

September 11, 2020 | Europe | News

Interview: Prof. Richard Watt on COVID-19 and the potential for dental reform

Though the spread of SARS-CoV-2 has had an undeniably deleterious effect on many elements of the dental world, it has also opened up new possibilities for imagining how dentistry should be delivered. That is the contention of Dr Richard Watt, professor of dental public health in the Department of Epidemiology and Public Health at University College London, in a recent letter to The Lancet. Watt spoke with Dental Tribune International about how points of emphasis in dentistry may change in a post-pandemic world.

details

February 25, 2020 | Americas | News

Botanical drug containing curcumin helps fight oral and oropharyngeal cancers

LOS ANGELES, U.S.: In a recent study, researchers examined the effect that APG-157, a botanical plant-based drug that contains curcumin and was developed under the U.S. Food and Drug Administration’s Botanical Drug Development: Guidance for Industry, has on neck and head cancer patients. The findings showed that the drug helps patients fight oral and oropharyngeal cancers by reducing the concentration of cytokines in the saliva and could serve as a therapeutic drug in combination with immunotherapy.

details

February 14, 2020 | Europe | News

General Dental Council figures show illegal tooth whitening procedures on the rise

LONDON, UK: In recent years, tooth whitening has become an increasingly common form of aesthetic dental treatment. Though its provision is legally limited to trained dental professionals, an investigation by the BBC has found that the number of reported illegal tooth whitening procedures in the UK rose by 26% in 2019.

details

December 6, 2019 | Americas | News

Smoking cessation may decrease risk of tooth loss

SÃO PAULO, Brazil: Smoking cessation has been shown to have a positive impact on the outcome of periodontal therapy. Previous reviews have addressed the association between smoking and tooth loss, which is the final outcome of periodontal disease. However, so far, no systematic review has evaluated the effect of smoking cessation on tooth loss. Therefore, researchers from the University of São Paulo School of Dentistry recently investigated this topic and found that former smokers show a decreased risk compared with current smokers.

details
International
Americas
Europe
Asia Pacific
Middle East & Africa

© 2020 - All rights reserved - Dental Tribune International